Hanover 16 is a UK-based family office investing European, US and Israeli companies. They focus especially on health tech, including digital health and pharmaceuticals, agro and food tech, including biotechnologies, next gen farms, and livestock, but are open to other businesses as well. They occasionally review especially interesting hardware cases, but are generally more focused on software, marketplaces and pharma.
They prefer companies with a commercial traction, ideally over 500ke annual revenue. They are typically a co-investor (not lead). They analyze startups in multiple different stages, with a preference for later stages all the way up to pre-IPO rounds.
For deal flow and cooperation please contact: invest@hanover16.com
Ticket size: €100k-€5,000k, sweet spot €1,000k, maximum allocation with follow-on investments €5,000k per company